Changwon Park

4.2k total citations
59 papers, 3.2k citations indexed

About

Changwon Park is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Changwon Park has authored 59 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 16 papers in Cell Biology and 8 papers in Cancer Research. Recurrent topics in Changwon Park's work include Angiogenesis and VEGF in Cancer (14 papers), Zebrafish Biomedical Research Applications (14 papers) and Pluripotent Stem Cells Research (9 papers). Changwon Park is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Zebrafish Biomedical Research Applications (14 papers) and Pluripotent Stem Cells Research (9 papers). Changwon Park collaborates with scholars based in United States, South Korea and Japan. Changwon Park's co-authors include Kyunghee Choi, Young‐sup Yoon, Jesse J. Lugus, Ji Woong Han, David M. Ornitz, Yun Shin Chung, Kory J. Lavine, Dong‐Wook Kim, Hyun‐Jai Cho and Asrar B. Malik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Changwon Park

53 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changwon Park United States 30 2.2k 590 423 346 335 59 3.2k
Roberto F. Nicosia United States 35 2.2k 1.0× 336 0.6× 469 1.1× 707 2.0× 257 0.8× 64 3.3k
Archana Sanjay United States 31 2.4k 1.0× 924 1.6× 239 0.6× 307 0.9× 147 0.4× 68 3.5k
Andrea Kolbus Austria 26 1.4k 0.6× 277 0.5× 167 0.4× 283 0.8× 287 0.9× 39 2.5k
Carmela Calés Spain 18 1.3k 0.6× 315 0.5× 175 0.4× 196 0.6× 251 0.7× 34 2.0k
Frédéric Mazurier France 29 1.6k 0.7× 268 0.5× 199 0.5× 457 1.3× 499 1.5× 67 2.8k
Shoutian Zhu United States 21 1.4k 0.6× 325 0.6× 382 0.9× 290 0.8× 225 0.7× 33 2.7k
Alexandra Le Bras Singapore 25 1.8k 0.8× 536 0.9× 239 0.6× 361 1.0× 109 0.3× 136 2.5k
Robert J. Lechleider United States 37 3.6k 1.6× 471 0.8× 275 0.7× 414 1.2× 331 1.0× 56 4.9k
Lu Q. Le United States 27 917 0.4× 285 0.5× 247 0.6× 262 0.8× 242 0.7× 71 2.5k
Bruce I. Terman United States 22 2.6k 1.2× 473 0.8× 204 0.5× 722 2.1× 131 0.4× 35 3.2k

Countries citing papers authored by Changwon Park

Since Specialization
Citations

This map shows the geographic impact of Changwon Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwon Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwon Park more than expected).

Fields of papers citing papers by Changwon Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changwon Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwon Park. The network helps show where Changwon Park may publish in the future.

Co-authorship network of co-authors of Changwon Park

This figure shows the co-authorship network connecting the top 25 collaborators of Changwon Park. A scholar is included among the top collaborators of Changwon Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changwon Park. Changwon Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Bum‐Yong, Jiwoong Choi, Victor Tseng, et al.. (2025). USP11 Promotes Endothelial Apoptosis-Resistance in Pulmonary Arterial Hypertension by Deubiquitinating HINT3. PubMed. 2(1). 10002–10002.
3.
Kim, Minseong, Yong‐hui Jiang, Esther Yang, et al.. (2025). Endothelial SHANK3 regulates tight junctions in the neonatal mouse blood-brain barrier through β-Catenin signaling. Nature Communications. 16(1). 1407–1407. 3 indexed citations
4.
Kim, Minseong, Sarah Chang, Ju Young Kim, et al.. (2024). PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension. Pulmonary Circulation. 14(4). e12448–e12448.
5.
Kim, Min Seong, Dong Hun Lee, Heesang Song, et al.. (2024). ETV2/ER71 regulates hematovascular lineage generation and vascularization through an H3K9 demethylase, KDM4A. iScience. 28(1). 111538–111538.
6.
Cho, Kyu-Won, Sangsung Kim, Jin Eyun Kim, et al.. (2023). Polycomb Group Protein CBX7 Represses Cardiomyocyte Proliferation Through Modulation of the TARDBP/RBM38 Axis. Circulation. 147(24). 1823–1842. 13 indexed citations
7.
Kim, Tae Min, et al.. (2023). ETV2/ER71, the key factor leading the paths to vascular regeneration and angiogenic reprogramming. Stem Cell Research & Therapy. 14(1). 14 indexed citations
8.
Kim, Min Seong, Shantel Vital, & Changwon Park. (2023). Protocol for the induction of hindlimb ischemia and isolation of muscle endothelial cells in mice. STAR Protocols. 4(1). 102017–102017. 3 indexed citations
9.
Kabir, Ashraf Ul, Dong Hun Lee, Xiaoli Wang, et al.. (2021). Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity. Science Translational Medicine. 13(583). 53 indexed citations
10.
Wongtrakool, Cherry, Junsuk Ko, Sarah Chang, et al.. (2020). MicroRNA-98 reduces nerve growth factor expression in nicotine-induced airway remodeling. Journal of Biological Chemistry. 295(52). 18051–18064. 7 indexed citations
11.
Kim, Ju Young, Dong Hun Lee, Hong Seo Choi, et al.. (2019). ETV2/ER71 regulates the generation of FLK1+ cells from mouse embryonic stem cells through miR-126-MAPK signaling. Stem Cell Research & Therapy. 10(1). 328–328. 11 indexed citations
12.
Oh, Se-Yeong, Ju Young Kim, & Changwon Park. (2015). The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development. Molecules and Cells. 38(12). 1029–1036. 42 indexed citations
13.
Lee, W. Robert, Kyu Chang Won, Chang Won Won, et al.. (2015). Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type. Acta Dermato Venereologica. 96(2). 245–250. 20 indexed citations
14.
Park, Changwon, Tae‐Jin Lee, Suk Ho Bhang, et al.. (2015). Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2. Arteriosclerosis Thrombosis and Vascular Biology. 36(1). 86–96. 50 indexed citations
15.
Oladipupo, Sunday S., Craig Smith, Andrea Santeford, et al.. (2014). Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proceedings of the National Academy of Sciences. 111(37). 13379–13384. 103 indexed citations
16.
17.
Lee, Dongjun, Changwon Park, Ho Lee, et al.. (2008). ER71 Acts Downstream of BMP, Notch, and Wnt Signaling in Blood and Vessel Progenitor Specification. Cell stem cell. 2(5). 497–507. 268 indexed citations
18.
Lugus, Jesse J., Changwon Park, & Kyunghee Choi. (2005). Developmental Relationship Between Hematopoietic and Endothelial Cells. Immunologic Research. 32(1-3). 57–74. 16 indexed citations
19.
Park, Changwon, Jesse J. Lugus, & Kyunghee Choi. (2005). Stepwise Commitment from Embryonic Stem to Hematopoietic and Endothelial Cells. Current topics in developmental biology. 66. 1–36. 13 indexed citations
20.
Won, Jonghwa, Yun‐Gyoung Hur, Eun Mi Hur, et al.. (2003). Rosmarinic acid inhibits TCR‐induced T cell activation and proliferation in an Lck‐dependent manner. European Journal of Immunology. 33(4). 870–879. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026